Lebwohl, M., Warren, R.B., Imafuku, S., Bagel, J., Armstrong, A.W., Passeron, T., Banerjee, S., Colombo, M.J., Scharnitz, T., Hoyt, K., Thaci, D. and Blauvelt, A. 2024. Deucravacitinib Long-Term Efficacy Through 4 years in Week 16 Placebo Crossover Patients in the Phase 3 POETYK PSO-1, PSO-2, and LTE Program. SKIN The Journal of Cutaneous Medicine. 8, 4 (Jul. 2024), s408. DOI:https://doi.org/10.25251/skin.8.supp.408.